1143 related articles for article (PubMed ID: 8590166)
1. Critical issues in the pathophysiology and management of peptic ulcer disease.
Hunt RH; Malfertheiner P; Yeomans ND; Hawkey CJ; Howden CW
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):685-99. PubMed ID: 8590166
[TBL] [Abstract][Full Text] [Related]
2. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK
Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114
[TBL] [Abstract][Full Text] [Related]
3. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
[TBL] [Abstract][Full Text] [Related]
4. Evidence-based clinical practice guidelines for peptic ulcer disease 2015.
Satoh K; Yoshino J; Akamatsu T; Itoh T; Kato M; Kamada T; Takagi A; Chiba T; Nomura S; Mizokami Y; Murakami K; Sakamoto C; Hiraishi H; Ichinose M; Uemura N; Goto H; Joh T; Miwa H; Sugano K; Shimosegawa T
J Gastroenterol; 2016 Mar; 51(3):177-94. PubMed ID: 26879862
[TBL] [Abstract][Full Text] [Related]
5. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy.
Bianchi Porro G; Parente F; Imbesi V; Montrone F; Caruso I
Gut; 1996 Jul; 39(1):22-6. PubMed ID: 8881802
[TBL] [Abstract][Full Text] [Related]
6. Successful eradication of Helicobacter pylori prevents relapse of peptic ulcer disease.
Tomita T; Fukuda Y; Tamura K; Tanaka J; Hida N; Kosaka T; Hori K; Sakagami T; Satomi M; Shimoyama T
Aliment Pharmacol Ther; 2002 Apr; 16 Suppl 2():204-9. PubMed ID: 11966543
[TBL] [Abstract][Full Text] [Related]
7. Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology.
Soll AH
JAMA; 1996 Feb; 275(8):622-9. PubMed ID: 8594244
[TBL] [Abstract][Full Text] [Related]
8. Review article: clinical aspects of Helicobacter pylori eradication therapy in peptic ulcer disease.
Penston JG
Aliment Pharmacol Ther; 1996 Aug; 10(4):469-86. PubMed ID: 8853751
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer.
Gisbert JP; Khorrami S; Carballo F; Calvet X; Gene E; Dominguez-Muñoz E
Aliment Pharmacol Ther; 2004 Mar; 19(6):617-29. PubMed ID: 15023164
[TBL] [Abstract][Full Text] [Related]
10. Optimal management of peptic ulcer disease in the elderly.
Pilotto A; Franceschi M; Maggi S; Addante F; Sancarlo D
Drugs Aging; 2010 Jul; 27(7):545-58. PubMed ID: 20583849
[TBL] [Abstract][Full Text] [Related]
11. Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding.
Howden CW
Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S5-11. PubMed ID: 10597118
[TBL] [Abstract][Full Text] [Related]
12. Peptic ulcer disease today.
Yuan Y; Padol IT; Hunt RH
Nat Clin Pract Gastroenterol Hepatol; 2006 Feb; 3(2):80-9. PubMed ID: 16456574
[TBL] [Abstract][Full Text] [Related]
13. Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people.
Ford AC; Gurusamy KS; Delaney B; Forman D; Moayyedi P
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD003840. PubMed ID: 27092708
[TBL] [Abstract][Full Text] [Related]
14. No Helicobacter pylori, no Helicobacter pylori-associated peptic ulcer disease.
Tytgat GN
Aliment Pharmacol Ther; 1995; 9 Suppl 1():39-42. PubMed ID: 7495941
[TBL] [Abstract][Full Text] [Related]
15. H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer.
Gisbert JP; Khorrami S; Carballo F; Calvet X; Gené E; Dominguez-Muñoz JE
Cochrane Database Syst Rev; 2003; (4):CD004062. PubMed ID: 14584003
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Helicobacter pylori eradication therapy in cirrhotic patients with peptic ulcer disease.
Mitrică D; Pleşa A; Constantinescu R; Drug V; Stanciu C
Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):367-74. PubMed ID: 21870725
[TBL] [Abstract][Full Text] [Related]
17. Study of outcome after targeted intervention for peptic ulcer resistant to acid suppression therapy.
Lanas A; Remacha B; Sáinz R; Hirschowitz BI
Am J Gastroenterol; 2000 Feb; 95(2):513-9. PubMed ID: 10685760
[TBL] [Abstract][Full Text] [Related]
18. An etiologic approach to management of duodenal and gastric ulcers.
Rex DK
J Fam Pract; 1994 Jan; 38(1):60-7. PubMed ID: 8289053
[TBL] [Abstract][Full Text] [Related]
19. H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer.
Gisbert JP; Khorrami S; Carballo F; Calvet X; Gené E; Dominguez-Muñoz JE
Cochrane Database Syst Rev; 2004; (2):CD004062. PubMed ID: 15106235
[TBL] [Abstract][Full Text] [Related]
20. Current guidelines for the eradication of Helicobacter pylori in peptic ulcer disease.
Rauws EA; van der Hulst RW
Drugs; 1995 Dec; 50(6):984-90. PubMed ID: 8612476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
